#Latest news with #1CrowdTime of India13-05-2025BusinessTime of IndiaBiopharma co Avammune raises $12 millionBENGALURU: Biopharmaceutical startup has raised $12 million (Rs 100 crore) co-led by , , and Kotak Lifesciences Fund I, with participation from and 1Crowd. Founded in 2020, Avammune is developing small molecule immunotherapies that activate the body's innate immune system to treat cancer and autoimmune disorders.
Time of India13-05-2025BusinessTime of IndiaBiopharma co Avammune raises $12 millionBENGALURU: Biopharmaceutical startup has raised $12 million (Rs 100 crore) co-led by , , and Kotak Lifesciences Fund I, with participation from and 1Crowd. Founded in 2020, Avammune is developing small molecule immunotherapies that activate the body's innate immune system to treat cancer and autoimmune disorders.
13-05-2025
